Skip to content

Operating Cash Flow at other companies

Eli Lilly logo
Eli LillyLLY
$5.33B+220%
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
-$32.44M+0.3%
Opko Health logo
Opko HealthOPK
-$19.31M+44.1%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-$60.58M-146%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
-$38.03M-5.9%
Erasca, Inc. logo
Erasca, Inc.ERAS
-$27.38M+13.2%

Other financials

Income statement

See full
Operating income-$58.0M-66.3%
Net income-$53.1M-74.7%
EPS (diluted)-$0.52-44.4%

Balance sheet

See full
Cash & equivalents$52.5M+3.8%
Total debt$956.0K-16.7%
Total equity$480.5M+25.3%
Total assets$530.6M+29.5%

Cash flow

See full
CapEx-
Free cash flow-$34.5M-27.8%

Valuation

See full
Market cap$973.05M+244%
Enterprise value$921.46M+295%

Returns & leverage

See full
Return on equity-42.9%+1.3pp
Debt / equity0.0×
Current ratio10.9×-4.3×

Where this comes from

Reported directly by Olema Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Olema Pharmaceuticals, Inc.'s operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Olema Pharmaceuticals, Inc.'s operating cash flow?
Olema Pharmaceuticals, Inc. (OLMA) reported operating cash flow of -$45.99M in Q1 2026.
How has Olema Pharmaceuticals, Inc.'s operating cash flow changed year-over-year?
Olema Pharmaceuticals, Inc.'s operating cash flow decreased by 4.6% year-over-year, from -$43.98M to -$45.99M.
What is the long-term trend for Olema Pharmaceuticals, Inc.'s operating cash flow?
Over 4 years (2021 to 2025), Olema Pharmaceuticals, Inc.'s operating cash flow has grown at a 30.4% compound annual growth rate (CAGR), from -$50.69M to -$146.72M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.